M. Focke‐Tejkl

发表

Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy

R. Valenta, T. Rülicke, A. Petersen, 2016, EBioMedicine.

Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation

R. Valenta, T. Popow-Kraupp, D. Blaas, 2010, European Respiratory Journal.

Molecular allergy diagnosis: A potential tool for the assessment of severity of grass pollen‐induced rhinitis in children

N. Papadopoulos, R. Valenta, B. Linhart, 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen

R. Valenta, P. Valent, W. Keller, 2016, PloS one.

Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis.

M. Wickman, R. Valenta, W. Thomas, 2015, The Journal of investigative dermatology.

University of Southern Denmark Infant milk formulas differ regarding their allergenic activity and induction of T-cell and cytokine responses Hochwallner,

R. Valenta, H. Hochwallner, U. Schulmeister, 2017 .

Specific Antibodies for the Detection of Alternaria Allergens and the Identification of Cross-Reactive Antigens in Other Fungi

R. Valenta, I. Swoboda, K. Sterflinger, 2016, International Archives of Allergy and Immunology.

Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction

R. Valenta, H. Grönlund, T. Thalhamer, 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Conversion of Der p 23, a New Major House Dust Mite Allergen, into a Hypoallergenic Vaccine

P. Valent, I. Swoboda, R. Valenta, 2014, The Journal of Immunology.

Dust Mite Allergen , into a Hypoallergenic Conversion of Der p 23 , a New Major House and

P. Valent, I. Swoboda, R. Valenta, 2014 .

Clustering of conformational IgE epitopes on the major dog allergen Can f 1

R. Valenta, W. Keller, I. Swoboda, 2017, Scientific Reports.

Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients

A. Heratizadeh, N. Novak, R. Valenta, 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Genetically Engineered and Synthetic Allergen Derivatives: Candidates for Vaccination against Type I Allergy

R. Valenta, H. Grönlund, A. Bugajska-Schretter, 1999, Biological chemistry.

Individuals with IgE antibodies to α‐Gal and CCD show specific IgG subclass responses different from subjects non‐sensitized to oligosaccharides

W. Hemmer, I. Swoboda, F. Altmann, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future

R. Valenta, V. Niederberger, M. Focke-Tejkl, 2016, The Journal of allergy and clinical immunology.

Clustering of conformational IgE epitopes on the major dog allergen Can f 1

R. Valenta, W. Keller, I. Swoboda, 2017, Scientific Reports.

Visualization of clustered IgE epitopes on alpha-lactalbumin.

N. Papadopoulos, B. Niggemann, R. Valenta, 2010, The Journal of allergy and clinical immunology.

Detection of genuine grass pollen sensitization in children by skin testing with a recombinant grass pollen hybrid

Rudolf Valenta, N. Papadopoulos, R. Valenta, 2018, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Recombinant allergens: what does the future hold?

R. Valenta, A. Neubauer, K. Niespodziana, 2011, The Journal of allergy and clinical immunology.

Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5

R. Valenta, S. Flicker, M. Ohlin, 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

IgE-mediated allergic responses (PP-021)

J. Silverberg, W. Thomas, A. Mari, 2010 .

Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.

A. Bugajska-Schretter, I. Swoboda, S. Spitzauer, 2002, Clinical allergy and immunology.

Vaccine Dust Mite Allergen, into a Hypoallergenic Conversion of Der P 23, a New Major House

P. Valent, R. Valenta, Katharina Blatt, 2022 .

Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction

T. Thalhamer, S. Spitzauer, Katharina Blatt, 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.